Data / Form D filings / STAGE I DIAGNOSTICS, INC.
STAGE I DIAGNOSTICS, INC.: Form D filings
STAGE I DIAGNOSTICS, INC., a biotechnology company in Little Rock, AR, filed 8 Form D notices with the SEC between 2009 and 2018. The latest, on July 17, 2018, reports $101,250 sold of a $2.5 million offering to 2 investors.
Find out what STAGE I DIAGNOSTICS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10912 COL. GLENN ROAD, SUITE 500, Little Rock, AR, 72204
- Phone
- (501) 353-0014
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1467094
The full lists. Form D filings in Arkansas: 214 rows, $10.70, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 17, 2018 | New notice | $2,500,000 | $101,250 | $2,398,750 | 2 | Jun 22, 2018 | sec.gov |
| May 14, 2018 | New notice | $219,655 | $219,655 | $0 | 7 | Apr 30, 2018 | sec.gov |
| Apr 12, 2017 | New notice | $500,000 | $198,215 | $301,785 | 7 | Mar 31, 2017 | sec.gov |
| Sep 30, 2016 | New notice | $95,000 | $60,250 | $34,750 | 2 | Sep 19, 2016 | sec.gov |
| Jun 9, 2016 | New notice | $500,000 | $100,000 | $400,000 | 4 | May 25, 2016 | sec.gov |
| Nov 26, 2014 | New notice | $700,000 | $301,250 | $398,750 | 3 | Nov 13, 2014 | sec.gov |
| Aug 15, 2012 | New notice | $2,500,000 | $20,000 | $2,480,000 | 1 | Jul 31, 2012 | sec.gov |
| Jun 25, 2009 | New notice | $1,000,000 | $100,000 | $900,000 | 3 | Jun 12, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| TIMOTHY J. O'BRIEN | Director, Promoter | |
| MICHAEL L. HIGGINS | Director | |
| MARY L. GOOD | Director | |
| DON E. FOWLER | Executive Officer, Director | |
| DENNIS L. STEARNS | Director | |
| BLAKE L. JOHNSON | Director |
Every Form D from the week of Jul 16, 2018 · All recent filings in Arkansas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what STAGE I DIAGNOSTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.